The effects of BMY-14802 against l-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat

Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: Predicting l-DOPA-induced dyskinesia

(2011) Gaynor A. Smith et al.   BEHAVIOURAL BRAIN RESEARCH

Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats

(2011) Kristin B. Dupre et al.   EXPERIMENTAL NEUROLOGY

Behavioral and Cellular Modulation of L-DOPA-Induced Dyskinesia by  -Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat

(2011) D. Lindenbach et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation

(2011) Corinne Y. Ostock et al.   NEUROPHARMACOLOGY

Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia

(2010) Daniella Rylander et al.   ANNALS OF NEUROLOGY

Sigma-1 receptors amplify dopamine D1 receptor signaling at presynaptic sites in the prelimbic cortex

(2010) Yingmei Fu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Effects of piclozotan (SUN N4057), a partial serotonin 1A receptor agonist, on motor complications induced by repeated administration of levodopa in parkinsonian rats

(2010) Yoshihiro Tani et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats

(2009) Christopher Bishop et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias

(2009) Melanie A. Paquette et al.   NEUROREPORT

Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia

(2009) Karen L. Eskow Jaunarajs et al.   NEUROREPORT

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

(2009) Melanie A. Paquette et al.   PSYCHOPHARMACOLOGY

Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats

(2009) C. Marin et al.   PSYCHOPHARMACOLOGY

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats

(2009) Karen L. Eskow et al.   SYNAPSE

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat

(2008) Kristin B. Dupre et al.   NEUROPHARMACOLOGY

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat

(2008) Kristin B. Dupre et al.   PSYCHOPHARMACOLOGY

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat

(2008) Anna R. Carta et al.   SYNAPSE

Motor complications in Parkinson disease: Clinical manifestations and management

(2007) Roongroj Bhidayasiri et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES